NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 57 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,000 | 0.0% | 17,155 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | -50.0% | 17,155 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $4,000 | 0.0% | 17,155 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $4,000 | -33.3% | 17,155 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $6,000 | 0.0% | 17,155 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $6,000 | – | 17,155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sowell Financial Services LLC | 1,507,457 | $593,000 | 0.17% |
Harel Insurance Investments & Financial Services Ltd. | 780,000 | $398,000 | 0.03% |
Spark Investment Management LLC | 353,400 | $180,000 | 0.01% |
LifePlan Financial Group, Inc | 28,810 | $15,000 | 0.01% |
Greenwich Wealth Management LLC | 60,066 | $31,000 | 0.01% |
SHINE INVESTMENT ADVISORY SERVICES INC | 19,608 | $10,000 | 0.01% |
Virtu KCG Holdings LLC | 336,414 | $172,000 | 0.01% |
LYNCH & ASSOCIATES/IN | 18,000 | $9,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $331,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 377,875 | $193,000 | 0.00% |